vs

Side-by-side financial comparison of Golden Matrix Group, Inc. (GMGI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $49.6M, roughly 1.7× Golden Matrix Group, Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -179.0%, a 140.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -15.8%). Over the past eight quarters, Golden Matrix Group, Inc.'s revenue compounded faster (104.6% CAGR vs 24.8%).

Golden Matrix Group Inc. is a global gaming tech firm that develops and licenses proprietary online gaming platforms, social casino products and interactive solutions. It serves B2B gaming operator clients across North America, Europe and Asia-Pacific, plus runs direct-to-consumer casual gaming properties.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GMGI vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.7× larger
PRCT
$83.1M
$49.6M
GMGI
Growing faster (revenue YoY)
PRCT
PRCT
+36.0% gap
PRCT
20.2%
-15.8%
GMGI
Higher net margin
PRCT
PRCT
140.9% more per $
PRCT
-38.1%
-179.0%
GMGI
Faster 2-yr revenue CAGR
GMGI
GMGI
Annualised
GMGI
104.6%
24.8%
PRCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GMGI
GMGI
PRCT
PRCT
Revenue
$49.6M
$83.1M
Net Profit
$-88.7M
$-31.6M
Gross Margin
57.5%
64.9%
Operating Margin
-188.3%
-4.1%
Net Margin
-179.0%
-38.1%
Revenue YoY
-15.8%
20.2%
Net Profit YoY
-4880.1%
-27.9%
EPS (diluted)
$-7.73
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GMGI
GMGI
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$49.6M
$76.4M
Q3 25
$47.3M
$83.3M
Q2 25
$43.2M
$79.2M
Q1 25
$42.7M
$69.2M
Q4 24
$58.9M
$68.2M
Q3 24
$41.0M
$58.4M
Q2 24
$39.4M
$53.4M
Net Profit
GMGI
GMGI
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-88.7M
$-29.8M
Q3 25
$566.0K
$-21.4M
Q2 25
$-3.6M
$-19.6M
Q1 25
$-231.6K
$-24.7M
Q4 24
$1.9M
$-18.9M
Q3 24
$-3.4M
$-21.0M
Q2 24
$64.9K
$-25.6M
Gross Margin
GMGI
GMGI
PRCT
PRCT
Q1 26
64.9%
Q4 25
57.5%
60.6%
Q3 25
55.8%
64.8%
Q2 25
56.4%
65.4%
Q1 25
56.6%
63.9%
Q4 24
69.8%
64.0%
Q3 24
54.7%
63.2%
Q2 24
55.0%
59.0%
Operating Margin
GMGI
GMGI
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-188.3%
-40.6%
Q3 25
-0.8%
-27.8%
Q2 25
-5.3%
-28.0%
Q1 25
-0.2%
-39.7%
Q4 24
5.6%
-28.9%
Q3 24
-2.4%
-38.4%
Q2 24
0.3%
-50.3%
Net Margin
GMGI
GMGI
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-179.0%
-39.1%
Q3 25
1.2%
-25.7%
Q2 25
-8.3%
-24.7%
Q1 25
-0.5%
-35.8%
Q4 24
3.2%
-27.6%
Q3 24
-8.3%
-35.9%
Q2 24
0.2%
-48.0%
EPS (diluted)
GMGI
GMGI
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-7.73
$-0.54
Q3 25
$0.00
$-0.38
Q2 25
$-0.03
$-0.35
Q1 25
$0.00
$-0.45
Q4 24
$-0.13
$-0.34
Q3 24
$-0.03
$-0.40
Q2 24
$0.00
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GMGI
GMGI
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$46.5M
$347.7M
Total Assets
$118.1M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GMGI
GMGI
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
GMGI
GMGI
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
GMGI
GMGI
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$46.5M
$365.9M
Q3 25
$123.5M
$380.3M
Q2 25
$121.3M
$385.8M
Q1 25
$108.5M
$389.2M
Q4 24
$105.1M
$402.2M
Q3 24
$94.3M
$241.2M
Q2 24
$90.4M
$251.8M
Total Assets
GMGI
GMGI
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$118.1M
$508.1M
Q3 25
$209.8M
$511.5M
Q2 25
$210.3M
$513.1M
Q1 25
$214.0M
$519.4M
Q4 24
$213.7M
$534.0M
Q3 24
$213.5M
$374.1M
Q2 24
$191.5M
$374.4M
Debt / Equity
GMGI
GMGI
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GMGI
GMGI
PRCT
PRCT
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$6.4M
FCF MarginFCF / Revenue
13.0%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$19.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GMGI
GMGI
PRCT
PRCT
Q1 26
Q4 25
$8.2M
$-10.3M
Q3 25
$7.0M
$-6.6M
Q2 25
$2.4M
$-15.0M
Q1 25
$7.7M
$-17.0M
Q4 24
$-32.4M
Q3 24
$4.8M
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
GMGI
GMGI
PRCT
PRCT
Q1 26
Q4 25
$6.4M
$-12.2M
Q3 25
$6.2M
$-9.5M
Q2 25
$-89.4K
$-17.8M
Q1 25
$6.6M
$-18.8M
Q4 24
$-33.6M
Q3 24
$2.3M
$-19.0M
Q2 24
$-16.8M
FCF Margin
GMGI
GMGI
PRCT
PRCT
Q1 26
Q4 25
13.0%
-15.9%
Q3 25
13.1%
-11.4%
Q2 25
-0.2%
-22.5%
Q1 25
15.5%
-27.2%
Q4 24
-49.2%
Q3 24
5.6%
-32.6%
Q2 24
-31.4%
Capex Intensity
GMGI
GMGI
PRCT
PRCT
Q1 26
Q4 25
3.6%
2.4%
Q3 25
1.8%
3.4%
Q2 25
5.7%
3.5%
Q1 25
2.6%
2.7%
Q4 24
1.7%
Q3 24
6.0%
0.4%
Q2 24
2.0%
Cash Conversion
GMGI
GMGI
PRCT
PRCT
Q1 26
Q4 25
Q3 25
12.42×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GMGI
GMGI

R Kings And CFAC$43.8M88%
Other$5.8M12%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons